Taiwan Study: Acetaminophen in Pregnancy Not Linked to Autism, ADHD Risk

A large, population-based study conducted in Taiwan is adding nuance to the ongoing debate surrounding acetaminophen employ during pregnancy and the potential risk of neurodevelopmental disorders in children. The research, published in JAMA Pediatrics, initially suggested a link between maternal acetaminophen prescriptions and an increased risk of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs). However, when researchers accounted for shared genetics and environment by focusing on siblings, that association largely disappeared.

The study analyzed data from over 2 million singleton births between 2004 and 2015, making it one of the largest investigations into this potential link to date. While initial analysis showed a 12% higher risk of ADHD and a 6% higher risk of ASD in children whose mothers had received acetaminophen prescriptions during pregnancy, a more refined sibling-matched analysis revealed no such association. This suggests that factors related to family background, rather than the medication itself, may play a more significant role.

Understanding the Complexity of the Link

Acetaminophen, similarly known as paracetamol, is a common over-the-counter medication used to relieve pain and reduce fever. It’s frequently recommended during pregnancy for managing discomfort. Concerns about its potential impact on fetal brain development arose from earlier studies that indicated a possible dose-response relationship – meaning the risk appeared to increase with higher doses or more frequent use.

However, establishing a causal link is incredibly challenging. Observational studies, like the one in Taiwan, can only demonstrate associations, not prove that one thing directly causes another. Numerous other factors – genetic predisposition, environmental influences, and other exposures during pregnancy – could contribute to the development of ADHD and ASD.

Researchers have attempted to address these complexities through various study designs. A study in Sweden, for example, employed a sibling-matched design and similarly failed to confirm the earlier associations. A Japanese study initially reported positive associations, but those results reversed when the data were analyzed using a sibling-matched approach.

Sibling Studies and the Challenge of Bias

The Taiwanese researchers went a step further, conducting a “bidirectional” analysis within the sibling data. This involved examining whether the results differed depending on which sibling – the older or the younger – was exposed to acetaminophen. They found that the outcome flipped depending on birth order, with a higher risk observed when the older sibling was exposed and a lower risk when the younger sibling was exposed. This finding highlights the potential for hidden biases even within sophisticated sibling-matched designs.

The researchers acknowledge that these inconsistencies suggest the sibling-matched approach, while helpful, may not entirely eliminate confounding factors. Changes in diagnostic patterns over time and across different regions could also contribute to the observed discrepancies. For instance, increased awareness of ASD and ADHD could lead to more diagnoses in recent years, potentially influencing the results.

What Does This Mean for Pregnant Individuals?

The findings from this study do not definitively rule out a potential link between acetaminophen use during pregnancy and neurodevelopmental disorders. However, they do suggest that the association is likely more complex than previously thought and may be influenced by factors beyond the medication itself.

It’s crucial to remember that acetaminophen remains a widely used and generally safe medication for managing pain and fever during pregnancy. The Food and Drug Administration (FDA) acknowledges the existing research but emphasizes that a causal relationship has not been established.

Pregnant individuals should not stop taking acetaminophen without consulting their healthcare provider. The benefits of managing pain and fever during pregnancy often outweigh the potential risks, especially when alternative treatments are not suitable.

The Ongoing Research and Future Directions

The debate surrounding acetaminophen and neurodevelopmental disorders is far from settled. Researchers are continuing to investigate this potential link using various approaches, including larger, more rigorously designed studies and investigations into the underlying biological mechanisms.

The Taiwanese team suggests that future studies should utilize sibling designs with investigator-led, age-standardized assessments to help reduce biases caused by changes in diagnostic patterns. This would involve directly assessing children’s neurodevelopmental outcomes using standardized tests, rather than relying solely on diagnostic codes from medical records.

a clearer understanding of this complex issue will require ongoing research, careful consideration of all available evidence, and open communication between healthcare providers and pregnant individuals. The goal is to provide informed guidance that supports both maternal health and optimal child development.

This article was written by Sanjukta Mondal, edited by Sadie Harley, and fact-checked and reviewed by Robert Egan.

Journal information: JAMA Pediatrics